<p>I was prescribed a medication for a chronic skin condition that my dermatologist had used routinely. What he did not tell me — and what I later learned had been documented in post-market studies the pharmaceutical company had suppressed — was that the drug carried a significant risk of acute liver toxicity in patients with my genetic profile. Eight months into the prescription I went into acute liver failure. I spent three weeks in the hospital, required two weeks in a step-down liver unit, and was told I had come within days of needing a transplant. My liver function has partially recovered but I have permanent damage.</p>
<p>I was 47, a commercial insurance broker. The hospitalization and recovery took me out of work for five months. My firm was understanding but the lost commissions were gone permanently. My attorney — who specialized in pharmaceutical litigation — said the suppressed study evidence gave us strong failure-to-warn claims against the manufacturer. Pharmaceutical cases of this type, however, are fought with enormous resources by drug companies and can take three or more years to resolve.</p>
<p>Pre-settlement funding came up in a patient advocacy group I had joined. I researched five companies over several days.</p>
<p>
America Lawsuit Loans was first. Pharmaceutical injury cases are at the complex end of the litigation spectrum — they involve medical causation experts, regulatory history, and corporate document discovery that makes them slow and expensive to litigate. When I explained my case to America Lawsuit Loans, their case manager understood what a failure-to-warn pharmaceutical claim looks like, what the damages structure typically involves, and what timelines I should realistically expect. They didn't treat my case like an auto accident. They assessed it as the serious, complex pharmaceutical litigation it was. The advance came quickly and my attorney said the process was smooth.</p>
<p>
Fund Capital America came in second. Their experience with serious medical injury cases showed in the quality of their case review.
Peachtree Financial earned third — long-established in the personal injury funding space, with competitive terms and professional handling of my complex file.</p>
<p>
Fund My Lawsuit Now placed fourth — fast and communicative, a strong option for anyone who needs to move quickly.
Baker Street Funding rounded out the five with a thorough and professional process that would suit any serious pharmaceutical case.</p>
<p>The case is in the document discovery phase. My attorney's team is working through the clinical trial records the manufacturer has been required to produce. The evidence so far has confirmed the suppression of safety data. America Lawsuit Loans has kept me financially stable enough to let this case build properly. Pharmaceutical companies count on injured patients running out of money. I have not.</p>
Locked
